A detailed history of Quadrature Capital LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 146,053 shares of MRNA stock, worth $3.62 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
146,053
Previous 65,343 123.52%
Holding current value
$3.62 Million
Previous $1.8 Billion 109.17%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$23.51 - $34.67 $1.9 Million - $2.8 Million
80,710 Added 123.52%
146,053 $3.77 Billion
Q2 2025

Aug 13, 2025

SELL
$23.65 - $28.54 $2.63 Million - $3.18 Million
-111,313 Reduced 63.01%
65,343 $1.8 Billion
Q1 2025

May 13, 2025

BUY
$28.35 - $47.53 $5.01 Million - $8.4 Million
176,656 New
176,656 $5 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.